Prot# 001-15: A Multicenter, Prospective, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study of BB3 to Reduce the Severity of Delayed Graft Function in Recipients of a Deceased Donor Kidney

Project: Research project

StatusActive
Effective start/end date7/19/187/19/21

Funding

  • Angion Biomedica Corp. (Prot# 001-15)